Multiple studies have documented the association between substance use, poor academic achievement, mental health problems, and bullying (1,2). A small but growing body of research suggests that family violence also is associated with bullying (3). To assess the association between family violence and other risk factors and being involved in or affected by bullying as a bully, victim, or bully-victim (those who reported being both bullies and victims of bullying), the Massachusetts Department of Public Health and CDC analyzed data from the 2009 Massachusetts Youth Health Survey. This report summarizes the results of that analysis, which showed significant differences in risk factors for persons in all three bullying categories, compared with persons who reported being neither bullies nor victims. The adjusted odds ratios (AORs) for middle school students for being physically hurt by a family member were 2.9 for victims, 4.4 for bullies, and 5.0 for bully-victims, and for witnessing violence in the family were 2.6, 2.9, and 3.9, respectively, after adjusting for potential differences by age group, sex, and race/ethnicity. For high school students, the AORs for being physically hurt by a family member were 2.8 for victims, 3.8 for bullies, and 5.4 for bully-victims, and for witnessing violence in the family were 2.3, 2.7, and 6.8, respectively. As schools and health departments continue to address the problem of bullying and its consequences, an understanding of the broad range of associated risk factors is important for creating successful prevention and intervention strategies that include involvement by families.
public middle schools and high schools. Sample sizes were 2,859 students from middle schools and 2,948 students from high schools. Response rates among students were 90.6% and 87.2% for middle schools and high schools, respectively. Cooperation rates were 61.6% for middle schools and 76.5% for high schools. Overall response rates were 55.8% for middle school students and 66.7% for high school students. A weight was applied to each survey record to adjust for school nonresponse, student nonresponse, and distribution of students by grade, sex, and race/ethnicity.
Students were asked two questions related to bullying. The first question was "During the past 12 months, how many times have you been bullied at school (being bullied included being repeatedly teased, threatened, hit, kicked, or excluded by another student or group of students)?" Response categories ranged from zero times to 12 or more times. Those who reported being bullied one or more times were categorized as victims. The second question, which immediately followed the first, consisted of two parts. Students were asked "Did you do any of the following in the past 12 months? a) bully or push someone around, and b) initiate or start a physical fight with someone." Response options for the second question were yes or no for each part. Those who responded yes to part "a" were categorized as bullies. Responses to part "b" were not considered in categorizing students as bullies because not enough information was available to determine whether or not initiating a physical fight should be considered bullying.
Responses to the two bullying questions were combined to create four mutually exclusive categories: 1) bullies were those who responded that they were not bullied but acknowledged that they were bullies, 2) victims were those who responded that they had been bullied but were not bullies, 3) bully-victims were those who responded both that they had been bullied and that they were bullies, and 4) "neither" were those who responded that they had been neither bullied nor were bullies. Students with missing responses to the two bully questions were excluded from analysis (55 middle school students and 39 high school students).
The questionnaires for middle schools and high schools included identical questions regarding demographics and suspected risk factors such as poor grades, mental and physical health, suicidality, experiences with family violence, overweight or obesity, and alcohol, tobacco, and drug use. Percentages of bullies, victims, bully-victims, and neither were calculated for each risk factor (bivariate analysis). Statistically significant differences were determined by whether the weighted estimates had overlapping or nonoverlapping 95% confidence intervals (CIs). In addition, AORs were calculated, controlling for age group, sex, and race/ethnicity using logistic regression for each outcome of interest, with "neither" as the reference group (multivariate analysis). AORs were considered statistically significant if CIs did not contain 1.0.
A greater percentage of middle school students (26.8%) than high school students (15.6%) were categorized as victims of bullying, and for both groups of students, the percentage of victims was greater than the percentage of bullies (7.5% for middle school and 8.4% for high school) and bully-victims (9.6% for middle school and 6.5% for high school) ( Table 1) . A significantly smaller percentage of middle school students (56.0%) than high school students (69.5%) were categorized as neither bullies nor victims. Among both middle school and high school students, a greater percentage of males (9.9% for middle school and 12.1% for high school) than females (5.0% for middle school and 4.8% for high school) were categorized as bullies. However, a greater percentage of females (29.8% for middle school and 17.8% for high school) than males (24.1% for middle school and 13.3% for high school) were categorized as victims. No significant difference between males and females was observed in the percentage categorized as bully-victims, either in middle school or high school.
Compared with students who were neither bullies nor bullying victims, both middle and high school bully-victims were more than three times as likely to report seriously considering suicide (24.9% versus 4.5% for middle school; 22.5% versus 6.2% for high school), intentionally injuring themselves (40.9% versus 8.4% for middle school; 28.5% versus 8.6% for high school), being physically hurt by a family member (23.2% versus 5.1% for middle school; 20.4% versus 4.7% for high school), and witnessing violence in their family (22.8% versus 6.6% for middle school; 30.6% versus 7.2% for high school) ( Table 2) .
Exposure to violent family encounters was more common among bully-victims than among bullies, and more common 
Editorial Note
This report presents the first state-specific data on a broad range of risk factors suspected to be associated with bullying among both middle school and high school students. The data indicate sizable prevalences of middle school (43.9%) and high school (30.5%) students involved in or affected by bullying. Among middle school students, 26.8% reported being victims of bullying, 7.5% acknowledged being bullies, and 9.6% Abbreviation: CI = confidence interval. * Odds ratios are adjusted for age group, sex, and race/ethnicity. Reference group is those students whose responses categorized them as neither victims nor bullies. † Students who responded 1) one or more to the question "During the past 12 months, how many times have you been bullied at school?" and 2) no to the question regarding whether they had bullied or pushed someone around. § Students who responded 1) yes to the question regarding whether they had bullied or pushed someone around and 2) zero to the question "During the past 12 months, how many times have you been bullied at school?" ¶ Students who responded 1) one or more to the question "During the past 12 months, how many times have you been bullied at school?" and 2) yes to the question regarding whether they had bullied or pushed someone around. ** Students who answered yes to the question "During the past 12 months, did you ever feel so sad or hopeless almost every day for 2 weeks or more in a row that you stopped doing some usual activities?" † † Students who responded "never" or "rarely" when asked how often they wore a seatbelt as a passenger. Other choices were "sometimes, " "most of the time, " and "always. " § § Includes students whose body mass index (BMI) was calculated as at or above the 85th percentile and lower than the 95th percentile (overweight) and students whose BMI was calculated as at or above the 95th percentile (obese) among persons of the same age and sex. ¶ ¶ Students who responded "fair" or "poor" when asked about their health in general. Other choices were "excellent, " "very good, " and "good. " *** Students who responded "extremely upset" when asked how their parents would react if they found out their child drank alcohol regularly. Other choices were "fairly upset, " "a little upset, " and "not upset at all. "
reported being bully-victims. Among high school students, 15.6% reported being victims of bullying, 8.4% acknowledged being bullies, and 6.5% reported being bully-victims. Multivariate analysis suggested associations between violent family encounters (i.e., being physically hurt or witnessing violence by a family member) and being bullied, bullying, and being a bully-victim. Bully-victims were more likely to report violent family encounters than bullies, and bullies were more likely to report such encounters than victims. This finding expands upon previous documentation of an association between childhood exposure to family violence and subsequent mental health problems (e.g., anxiety and depression) (4) and involvement in general physical aggression, dating violence, and weapon-carrying (5). The results underscore the importance of primary bullying prevention programs and of comprehensive programs and strategies that involve families. Although evidence of bullying prevention programs changing behavior among U.S. students is mixed (6), several violence prevention programs and strategies, including some involving families, have demonstrated effectiveness in decreasing violent behavior.*
The results from this study are consistent with previous findings showing that 1) risks for both depression and suicide are higher among bullies and victims (7), 2) many risk factors are more common among bully-victims than students categorized as bullies or victims (7-9), and 3) being a bully is associated with alcohol and drug use (2, 9) . These results differ from those presented in some studies (2, 8) , which found males more likely to be bullies and victims. However, in this report, bullying victimization is defined broadly, encompassing physical, verbal, and relational bullying. Because relational bullying, such as social exclusion and spreading rumors, is more prevalent among females (3), inclusion of this type of bullying might account for the difference.
The findings in this report are subject to at least five limitations. First, this was a cross-sectional study, and causality cannot be implied. Second, the relatively low overall response rate among middle school students (55.8%) might limit the generalizability of the data, although the sample included classes in 69 middle schools across the state, and no differences were observed by region, urban/rural classification, or student enrollment between schools that chose to participate and those that declined. In addition, the sample was limited to students attending public schools; some data have shown that students attending public schools are more likely than students attending private schools to be bullied (10) . Third, the definition of being bullied (i.e., being repeatedly teased, threatened, hit, kicked, or excluded by another student or group of students) was much more specific than the definition for bullying (i.e., bully or push someone around), which might account, at least in part, for the greater prevalence of victims than bullies and bully-victims. Fourth, all data were self-reported and subject to recall and social desirability bias. Finally, the sample was limited to students present on the day of survey administration. Those bullied are absent more frequently (9) and, therefore, less likely to be included in the sample.
Bullying is a pervasive public health problem requiring comprehensive solutions. Evidence suggests that classroom prevention programs alone in the United States often are unsuccessful in changing bullying behaviors (6) . In May 2010, Massachusetts joined 44 other states with similar laws by enacting a comprehensive bullying prevention law that covers all types of bullying and requires all school districts to develop, adhere to, and update a plan to address bullying prevention and intervention in consultation with school staff members, families, and community members.
To assist schools in their efforts to implement comprehensive strategies to prevent bullying, other types of violence, and unintentional injuries, CDC developed School Health Guidelines to Prevent Unintentional Injuries and Violence. These guidelines include the following recommendations: 1) establish a social school environment that promotes safety; 2) provide access to health and mental health services; 3) integrate school, family, and community prevention efforts; and 4) provide training to enable staff members to promote safety and prevent violence effectively. Because bullying is associated with many other risk factors, including exposure to violence outside of the school setting, comprehensive strategies that encompass the school, family, and community are most likely to be effective. To assist schools and communities in their efforts to prevent youth violence, including bullying, CDC has launched the national initiative, Striving To Reduce Youth What is already known on this topic?
Studies have documented associations between bullying and substance use, poor academic achievement, and mental health problems, and a limited number of studies have indicated an association with family violence.
What is added by this report?
The findings of increased risk for bullies, victims, and bullyvictims of being physically hurt by a family member or witnessing family violence underscore the association between bullying and events outside of the school.
What are the implications for public health practice?
A comprehensive approach that encompasses school officials, students, and their families is needed to prevent bullying among middle school and high school students.
Violence Everywhere (STRYVE), which promotes increased awareness that youth violence can be prevented using strategies based on the best available evidence. Links to resources are available on the STRYVE website (http://www.cdc.gov/ violenceprevention/stryve).
Secondhand smoke (SHS) exposure causes lung cancer and cardiovascular and respiratory diseases in nonsmoking adults and children, resulting in an estimated 46,000 heart disease deaths and 3,400 lung cancer deaths among U.S. nonsmoking adults each year (1) . Smoke-free laws that prohibit smoking in all indoor areas of a venue fully protect nonsmokers from involuntary exposure to SHS indoors (1) This report focuses on laws that completely prohibit smoking in private-sector worksites, restaurants, and bars. These three venues were selected because they are a major source of SHS exposure for nonsmoking employees and the public (1). CDC considers a state smoke-free law to be comprehensive if it prohibits smoking in these three venues. Some states have enacted laws with less stringent smoking restrictions (e.g., provisions restricting smoking to designated areas or to separately ventilated areas); however, these laws are not effective in eliminating SHS exposure. The Surgeon General has concluded that the only way to fully protect nonsmokers from SHS exposure is to prohibit smoking in all indoor areas, and that separating smokers from nonsmokers, cleaning the air, and ventilating buildings cannot eliminate SHS exposure (1) .
Data on state smoking restrictions for this report were obtained from CDC's State Tobacco Activities Tracking and Evaluation (STATE) System database, which contains tobaccorelated epidemiologic and economic data and information on state tobacco-related legislation.* State legislation is collected quarterly from an online legal research database of state laws and is analyzed, coded, and entered into the STATE System. The STATE System contains information on state tobaccorelated laws, including smoke-free policies, in effect since the fourth quarter of 1995. In addition to information on state smoking restrictions in worksites, restaurants, and bars, the STATE System contains information on state smoking restrictions in other venues, including government worksites, commercial and home-based child care centers, multiunit housing, vehicles, hospitals, prisons, and hotels and motels. The years listed are the years in which the laws took effect; in some cases the laws were enacted in a preceding year. Some state laws were expanded gradually or phased in; in these cases, the year provided is the year when the law first applied to all three of the settings considered in this study. Additionally, while most of these laws were enacted through the state legislative process, Arizona, Ohio, South Dakota, and Washington enacted their laws through ballot measures.
As of December 31, 2010, in addition to the 26 states with comprehensive smoke-free laws, 10 states had enacted laws that prohibit smoking in one or two, but not all three, of the venues included in this study (Table 2) . Additionally, eight states had passed less restrictive laws (e.g., laws allowing smoking in designated areas or areas with separate ventilation). Finally, seven states have no statewide smoking restrictions in place for private worksites, restaurants, or bars ( Table 2) . Of note, only three southern states (Florida, Louisiana, and North Carolina) have laws that prohibit smoking in any two of the three venues examined in this report, and no southern state has a comprehensive state smoke-free law in effect ( Figure) . 
A Healthy People 2020 † objective (TU-13) calls for all states to enact laws on smoke-free indoor air that prohibit smoking in public places and worksites. Smoke-free laws substantially improve indoor air quality, reduce SHS exposure and related health problems among nonsmokers, help smokers quit, change social norms regarding the acceptability of smoking, and reduce heart attack and asthma hospitalizations (1) (2) (3) (4) (5) . The findings in this analysis indicate that the United States made considerable progress during the past decade in increasing the number of states with comprehensive smoke-free laws that prohibit smoking in all indoor areas of worksites, restaurants, and bars, and increasing the number of U.S. residents protected by such laws. As of December 31, 2010, 26 states have implemented comprehensive smoke-free laws, and almost half (47.8%) of U.S. residents are covered by comprehensive state or local smoke-free laws. § Despite this progress, approximately 88 million nonsmokers aged ≥3 years in the United States are exposed to SHS, as determined from levels of serum cotinine (a biological marker for SHS exposure) measured as part of the 2007-2008 National Health and Nutrition Examination Survey (6) .
Before Delaware passed its smoke-free law in 2002, no state had adopted a comprehensive law making private workplaces, restaurants, and bars smoke-free. California's state smoking restrictions were enacted in 1994, but the law allows exemptions for smoking in ventilated employee smoking rooms, an exemption that remains in effect. Although a Utah law prohibiting smoking in restaurants took effect in 1995, smoking was still allowed in worksites and bars in that state until 2009. Comprehensive smoke-free laws were rare even at the local level until the 2000s. In 1990, the community of San Luis Obispo, California, adopted the first law in the United States eliminating smoking in bars. During the 1990s, smoke-free bar laws were largely limited to communities in California and Massachusetts.
The progress made during the past decade in enacting comprehensive state smoke-free laws is an extraordinary public health achievement. In the span of 10 years, smoke-free workplaces, restaurants, and bars went from being relatively rare to being the norm in half of the states and DC. Several factors appear to have contributed to this outcome. First, smoke-free laws increasingly were viewed as a worker protection measure that should apply to all employees, including those in restaurants and bars (1) . Second, as state and local smoke-free laws were enacted across the country, other states and communities learned from the experiences of similar jurisdictions and were able to adapt and implement such laws (1,7). For example, New York City's adoption of a comprehensive smoke-free law in 2002 drew substantial news media coverage and established that a smoke-free law could be implemented successfully in a large, diverse, metropolitan setting (1). Finally, the Surgeon General's 2006 report, The Health Consequences of Involuntary Exposure to Tobacco Smoke (1), presented several important conclusions about the health risks associated with SHS exposure and effective protection approaches, generated extensive news media coverage, and was cited by a number of state and local policymakers as influencing their decisions on this topic. Of the 26 states that adopted comprehensive smoke-free laws, 16 did so after this report was released.
Even among the 26 states that have comprehensive smokefree laws in effect, protections could be extended to locations that are typically exempted from state laws. For example, casino workers are heavily exposed to SHS on the job and could benefit from smoke-free policies that protect them (8) . In addition, policies that prohibit smoking in the common areas and individual units (i.e., living areas) of apartments could protect nonsmoking residents, including children, from SHS infiltration from adjoining units (9, 10) . This is because SHS from apartment units where smoking occurs can penetrate into units in the same building that are occupied by nonsmokers (9, 10) .
The findings in this report are subject to at least two limitations. First, the STATE System only captures information on certain types of state smoking restrictions, primarily statutory laws and executive orders, and does not include information on state administrative laws, regulations, or implementation guidelines. As a result, the manner in which a state smoking restriction is implemented or enforced in practice might differ from how it is coded in the STATE System. Finally, the STATE System only collects state-level data; it does not capture information on local smoking restrictions.
Despite the substantial progress made nationally in the past decade, southern states lack statewide laws that prohibit smoking in worksites, restaurants, and bars. However, while no southern states have a comprehensive smoke-free law in effect, many communities in these states have adopted comprehensive local smoke-free laws. ¶ All states that have not done so already could protect the health of their residents by adopting laws that prohibit smoking in workplaces, restaurants, and bars. The Healthy People 2020 target of enacting smoke-free indoor air laws that prohibit smoking in public places and worksites in What is already known on this topic?
In 2006, the Surgeon General reported that no level of exposure to secondhand smoke (SHS) is risk-free; the only effective way to eliminate involuntary exposure to SHS is to completely eliminate smoking in all indoor areas.
The number of states that enacted statewide comprehensive smoke-free policies (i.e., no smoking allowed in workplaces, restaurants, and bars) increased sharply, from zero states in 2000 to 26 states in 2010, and almost half of U.S. residents now are covered by comprehensive state or local smoke-free laws.
If current efforts in statewide smoke-free policy adoption continue, all states could have comprehensive smoke-free policies by 2020. However, this will require accelerated progress in the South, where no state currently has a comprehensive state smoke-free law in effect. ¶ Additional information is available at http://www.no-smoke.org/pdf/percentstatepops.pdf. 
The Problem
In 2009, malaria, a disease transmitted by the bite of an infective Anopheles mosquito, caused an estimated 225 million clinical cases and 781,000 deaths worldwide, of which more than 90% occurred in children aged <5 years in Africa (1) . Approximately half of the world's population, or 3 billion persons, are at risk for acquiring the illness. Malaria is transmitted most intensely in central and western Africa, where in some areas >40% of children aged <10 years are infected and residents can be bitten by more than one infective mosquito every day of the year (2) .
Malaria in humans is caused mainly by four species of the intra-erythrocytic parasite Plasmodium, of which Plasmodium falciparum and P. vivax account for most morbidity worldwide. P. falciparum malaria is the most dangerous and can be fatal in 15%−20% of cases, even when appropriately treated. Death results from severe anemia, seizures and coma, acute respiratory distress syndrome, and other organ failures. P. falciparum also is the species in which resistance to multiple antimalarials has appeared over the past 50 years. The burden of P. falciparum includes placental infection that increases the risk for low birth weight and subsequent infant mortality or disability. In countries with a high incidence of malaria, economic growth during 1965-1990 was lower by 1.3% per year, compared with countries without high malaria incidence, even after adjusting for other factors (3).
Efforts to combat malaria encompass a continuum from control (reduction of malaria morbidity and mortality) to elimination (cessation of transmission in a defined geographic area) and eradication (global reduction of malaria incidence to zero). The global malaria eradication campaign of the mid-20th century eliminated malaria in 37 of 143 countries where malaria was endemic in 1950, and many other countries substantially decreased malaria incidence and deaths. However, the campaign did not eradicate malaria. Technical setbacks, implementation difficulties, and a paucity of research to find solutions limited success. In 1969, the 22nd World Health Assembly acknowledged the failure of the global eradication campaign, suspended it indefinitely, and consequently placed new emphasis on improving malaria control to minimize the burden of disease. In the late 1980s and early 1990s, efforts to control malaria were hampered as a result of decreased funding and support and the spread of parasites resistant to antimalarial drugs.
Today, malaria control in areas with high incidence is based on strategic implementation and scale-up of proven, cost-effective interventions. The aim is first to rapidly reduce malaria morbidity and mortality, particularly among high-risk groups such as children and pregnant women, followed by progressive reduction of transmission and elimination from malaria-endemic areas (Figure 1 ). Global eradication remains the ultimate long-term goal, although it is now approached with perhaps a greater appreciation of its challenges.
Currently Recommended Interventions for Malaria Control
Four proven interventions currently are being scaled up across sub-Saharan Africa: 1) long-lasting insecticide-treated mosquito nets (ITNs), 2) indoor residual spraying (IRS), 3) diagnosis and treatment of infected persons with artemisininbased combination therapy (ACT), and 4) protection of women with intermittent preventive treatment during pregnancy (IPTp).
ITNs, evaluated through field trials, have demonstrated a protective efficacy of 17% against all-cause childhood mortality in sub-Saharan Africa and could save up to 5.5 lives each year for every 1,000 children protected (4). Follow-up field trial data show that the child survival benefit from ITNs can last for up to 6 years (5). Additionally, expanding the availability of nets from target groups (pregnant women and children aged <5 years) to cover at least 65% of older children and adults provides some protection even for those without nets (e.g., by reducing mosquito survival and decreasing community parasitemia) (6) . These findings, and the availability of funding, led to a policy aimed at achieving universal coverage rather than a focus on vulnerable groups (7) .
IRS is the application of insecticide to the interior walls of houses. Ideally, the insecticide will repel mosquitoes from entering houses and kill them when they rest on treated walls, thus reducing transmission from mosquitoes that bite and rest indoors. Field studies and program experience since the 1950s have demonstrated the effectiveness of IRS in reducing malaria in both stable and unstable (epidemic-prone) malaria transmission settings (8 ITN effectiveness is threatened by the emergence of insecticide resistance (9) . Novel applications of IRS using rotational (alternating insecticides over time) or mosaic (multiple insecticides in different areas) strategies might preserve the effectiveness of this intervention.
Diagnosis and management of patients with malaria is a cornerstone of malaria control because this can cure clinical disease and blunt transmission. During a period of poor malaria control in the 1990s, P. falciparum infection accounted for an estimated 30% of childhood deaths in sub-Saharan Africa (10); a large proportion of these malaria-related deaths could be attributed to the high prevalence of parasites resistant to chloroquine, the first-line treatment during this period. In the last decade, a potent new class of drug made from derivatives of artemisinin has been introduced. To forestall the development of resistance to artemisinin derivatives, the World Health Organization (WHO) recommends that the derivatives not be used alone, but rather as artemisinin-based combination therapy (ACT) (using an artemisinin in combination with another antimalarial with a different mode of action); ACT regimens have been adopted as first-line treatment globally (11) . Rapid and accurate diagnosis enhances malaria case management by directing ACTs to patients with a confirmed diagnosis of malaria. Recently, malaria rapid diagnostic tests based on lateral-flow immunochromatography have been introduced. They can detect malaria parasite antigens from finger-prick blood specimens in 10-15 minutes, and their availability has begun to increase the ability of health-care workers to diagnose cases, especially in rural areas without laboratory capacity.
In sub-Saharan Africa, an estimated 28% of women are infected with P. falciparum during pregnancy. Because of pregnancy-altered changes in immunity, women living in moderate-to high-transmission areas who are pregnant for the first or second time are at greater risk for adverse events from malaria than women who have had three or more pregnancies (12) . In these transmission contexts, IPTp, the preventive treatment of all pregnant women with curative regimens of sulfadoxine pyrimethamine (SP) during the second and third trimesters, can decrease both placental malaria parasitemia and maternal anemia (13) . In many areas where SP is used for IPTp, a high prevalence of parasites with SP resistance genes 
Progress and Strategies Toward Malaria Eradication
Developments at the turn of the millennium gave rise to renewed optimism for malaria control. Global partnerships to coordinate work were established, notably the Roll Back Malaria (RBM) partnership (information available at http://www.rollbackmalaria.org). Unprecedented funding for program scale-up became available through donor mechanisms such as the Global Fund to Fight AIDS, Tuberculosis, and Malaria; the World Bank; and the U.S. President's Malaria Initiative. Leaders in malaria-endemic countries committed to malaria control as a national priority through assent to RBM's Abuja Declaration and adoption of UN Millennium Development Goals.
In many countries, more money, applied science, and enhanced global partnerships are beginning to result in decreased malaria. Coverage of key interventions, such as ITNs, is increasing, although most countries have yet to achieve their targets; recent household surveys from African countries such as Rwanda and the Gambia show that approximately 50% or more of children aged <5 years sleep under ITNs. However, coverage is low for other countries, including Nigeria and Democratic Republic of the Congo (Figure 2 on a national scale are only beginning to be seen; for example, in seven countries (Ghana, Kenya, Madagascar, Rwanda, Senegal, Tanzania, and Zambia), reductions in all-cause mortality in children aged <5 years ranged from 19%-36% in paired nationwide household surveys following the scale-up of malaria control (15) . While a variety of factors might be influencing the decline in mortality rates of children, strong and growing evidence indicates that malaria prevention and treatment efforts have played a major role (16) . Thorough impact assessments are under way in several countries to examine this relationship. Although current malaria control efforts are showing promising results in some countries, many others have yet to achieve targets (14) . One reason is the relatively short period that increased resources have been available. Also, even though the funds put toward malaria control have increased substantially since 2003, the total resources available globally to scale-up malaria control interventions fall far short of what is needed. To ensure the maximal effect from implemented interventions, barriers to scale-up should be identified and eliminated, and these efforts should cover all aspects of current interventions, from determining optimal approaches to ITN distribution and IRS implementation to diagnostic and treatment protocols for case management and IPTp policies.
Even when targets for scale-up of recommended interventions are achieved, most experts agree that because of the very high transmission rate in sub-Saharan Africa, additional investments in research and development of new control and elimination tools will be required before malaria can be eradicated. Recently published research recommendations emphasize that the longterm vision for malaria interventions should include new antimalarial medications, evaluation of treatment strategies such as mass drug administration, and novel vectorcontrol approaches (17) . In regions with less malaria endemicity, elimination might rest on novel molecular assays capable of detecting low numbers of parasites among persons in remote, rural areas; novel diagnostic technology such as real-time fluorescence loop-mediated amplification might make parasite detection possible in the absence of reference laboratory personnel and equipment (18) .
The availability of vaccines has been critical in targeting diseases for global eradication. Unfortunately, a highly effective vaccine for malaria control has not been found, although several promising candidates are in development. Currently the first Phase III, individually randomized, clinical trial of a malaria vaccine is being conducted, advancing earlier work that demonstrated that the candidate vaccine was associated with a 35% reduction in clinical illness from malaria and a 49% reduction of severe malaria in children for up to 6 months (19).
Conclusion
Malaria is an enormous global disease burden, and its eradication is an ambitious goal. Although the tools for malaria control are much improved, to ensure continued progress, national programs, local communities, global health partners, and donors will have to build on initial successes, maintain a prolonged commitment, and invest in strategies for the future. This will require leadership, perseverance, flexibility, and financial support. Research into new medications, insecticides, and vaccines will be required to achieve the eventual goal of eradication. Organizations working toward malaria eradication should be pleased with the progress so far, cautioned by the challenges ahead, and heartened with confidence that the implementing foundation is solid and science is guiding the way. 
World Malaria Day -April 25, 2011
World Malaria Day is commemorated on April 25, the date in 2000 when 44 African leaders met in Abuja, Nigeria, and signed the Abuja Declaration, committing their countries to cutting malaria deaths in half by 2010. In the decade since, increased funding and efforts have led to a scale-up of effective malaria interventions in many countries. In 2009, malaria caused an estimated 781,000 deaths worldwide, down from an estimated 985,000 in 2000. In 32 of the 56 malaria-endemic countries outside Africa, the number of confirmed malaria cases declined more than 50%. By 2010, 11 countries and one area in the World Health Organization's African Region showed a reduction of more than 50% in confirmed malaria cases or admissions and deaths (1) .
The theme of World Malaria Day, "Achieving Progress and Impact," highlights the successes worldwide and provides an opportunity to take stock of the current state of malaria globally and to consider how to achieve the U.N Secretary-General's goal of near zero deaths by 2015. CDC contributes to these efforts through the President's Malaria Initiative (PMI), a U.S. government interagency initiative to reduce malaria in 17 countries in sub-Saharan Africa and in the Greater Mekong subregion in Asia. PMI is led by the U.S. Agency for International Development (USAID) and is implemented by USAID and CDC, in collaboration with host ministries of health and local and international partners.
CDC also conducts multidisciplinary strategic and applied research globally to better understand malaria and develop safe, effective interventions that can lead to malaria's elimination and eventual eradication. Additional information regarding CDC's malaria activities is available at http://www.cdc.gov/malaria. 
National Infant Immunization WeekApril 23-30, 2011
CDC observes the 17th annual National Infant Immunization Week (NIIW) during April 23-30, 2011. Local and state health departments, national immunization partners, health-care professionals, and community leaders from across the country will collaborate to highlight the achievements and benefits of immunization through community-wide activities and events, including grand rounds and educational training for health-care professionals and parents, media briefings, and immunization clinics.
NIIW is now part of a broad global initiative that is held in conjunction with the Pan American Health Organization's (PAHO) Vaccination Week in the Americas. Ten border states have partnered with PAHO and the United States-Mexico Border Health Commission to bring additional focus to infant immunization in the U.S.-Mexico border region. In addition, the World Health Organization's European, Eastern Mediterranean, and African regions also are observing simultaneous immunization weeks. In all, approximately 100 countries are expected to participate in the week-long campaign to call attention to the critical role that vaccination plays in safeguarding public health globally.
Currently, in the United States, CDC recommends that children aged ≤2 years receive vaccines to protect against 14 diseases (1). In September 2010, CDC announced that childhood immunization rates for vaccines routinely recommended for children remain at or near record highs (2) . Parental acceptance of routine childhood immunization is essential because high vaccination coverage results in decreased rates of vaccine-preventable diseases. Results from a recent survey of U.S. parents with children aged <6 years show that a majority of parents are confident or very confident in vaccine safety (79.0%) and believe that vaccines are important to children's health (79.8%) (3). This same survey showed that health-care providers are parents' most important source of information for making decisions regarding vaccination (81.7%). To help facilitate communication between health-care providers and parents about vaccines, vaccine safety, and vaccine-preventable diseases, CDC, the American Academy of Pediatrics, and the American Academy of Family Physicians have developed a series of educational materials called Provider Resources for Vaccine Conversations with Parents (available at http://www. cdc.gov/vaccines/conversations). These resources will be a focus of this week's NIIW educational efforts. Additional information about NIIW is available at http://www.cdc.gov/ vaccines/events/niiw. Table II. † † Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 3, 2010, 95 influenza-associated pediatric deaths occurring during the 2010-11 influenza season have been reported. § § The six measles cases reported for the current week were imported. ¶ ¶ Data for meningococcal disease (all serogroups) are available in Table II Table II Table IV , which appears quarterly. † Contains data reported through the National Electronic Disease Surveillance System (NEDSS). Rico  -104  550  191  1,538  -2 Table IV , which appears quarterly. † Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage, other clinical and unknown case classifications. § DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF. ¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS). Table IV , which appears quarterly. † Cumulative total E. ewingii cases reported for year 2010 = 11, and 1 case report for 2011. § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). 2  26  54  240  339  67  102  206  1,396  1,374  1  3  9  46  43  Connecticut  -3  12  -1  -38  169  499  612  -0  6  --Maine  §  1  3  11  29  50  -2  7  44  69  -0  2  7  1  Massachusetts  -14  25  147  179  55  49  81  704  561  -2  6  30  31  New Hampshire  -2  10  18  44  2  3  7  33  41  -0  1  4  5  Rhode Island  §  -1  7  7  19  9  5  15  108  81  -0  2  3  5  Vermont  §  1  4  10  39  46  1  0  17  8  10  1  0  3 Table IV , which appears quarterly. † Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I . § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). Table IV , which appears quarterly. † Contains data reported through the National Electronic Disease Surveillance System (NEDSS). 5  10  27  81  104  27  57  178  411  599  3  7  44  79  104  Delaware  -0  3  1  3  3  10  33  107  157  -0  1  -1  District of Columbia  -0  4  -1  -0  4  3  3  -0  2  3  4  Florida  2  3  9  41  45  4  1  8  18  16  2  2  7  25  35  Georgia  1  1  4  3  14  -0  2  1  2  -1  7  12  16  Maryland  †  1  2  6  13  25  10  22  106  159  269  1  1  24  15  15  North Carolina  -1  7  10  5  1  0  9  10  37  -0  13  8  20  South Carolina  †  -0  2  3  1  -0  3  1 -0  2  -1  -0  0  ---0  1  -1  Louisiana  -0  3  6  1  -0  1  ---0  1  -1  Oklahoma  -0  3  1  --0  0  --1  0  1  2  2  Texas  †  -2  7  10  17  -2  22  6  15  -1  16  10  16   Mountain  1  3  10  20  44  -0  3  2  2  -1  4  11  16  Arizona  -1  7  7  11  -0  1  1  --0  3  3  6  Colorado  1  0  2  2  11  -0  1  ---0  3  3  5  Idaho  †  -0  1 7  5  15  102  84  -3  11  40  47  5  4  10  40  29  Alaska  -0  2  ---0  1  -1  -0  2  2  1  California  7  4  14  91  76  -2  8  27  27  3  2  9  30  21  Hawaii  -0  1  1  -N  0  0  N  N  -0  1  --Oregon  -0  3  2  1  -0  3  13  19  -0  3  3  2  Washington  -0  5  8  7  -0  3  --2  0  5  5 5 Table IV , which appears quarterly. † Contains data reported through the National Electronic Disease Surveillance System (NEDSS). 8  14  38  236  285  2  13  220  94  1,089  95  544  2,175  3,630  3,382  New England  -0  3  11  4  -0  2  1  15  1  10  24  102  76  Connecticut  -0  1  1  --0  1  -10  -1  8  -10  Maine  §  -0  1  3  --0  1  -1  1  1  8  41  5  Massachusetts  -0  2  7  2  -0  2  1  4  -5  13  45  53  New Hampshire  -0  0  ---0  1  ---0  3  12  3  Rhode Island  §  -0  1  ---0  0  ---0  7  3  3  Vermont  §  -0  1  -2  -0  0  ---0  4 -0  0  ---0  0  -2  -0  2  1  1  Florida  2  1  3  15  29  2  0  2  3  5  5  6  28  91  52  Georgia  1  0  2  2  4  -0  2  1  --5  13  61  55  Maryland  §  -0  1  3  2  -0  1  -5  -2  6  27  44  North Carolina  -0  3  8  8  -0  2  -2  7  3  35  84  126  South Carolina  §  -0  1  4  4  -0  1  -3  -6  25  43  53  Virginia  §  -0  2  8  11  -0  2  1  5  2  7  39  89  33  West Virginia  -0  1  -1  -0  0  -2  -0  41  -6 E.S. Central  -1  3  11  13  -0  2  3  3  1  13  35  110  238  Alabama  §  -0  1  6  2  -0  2  1  1  -4  8  30  58  Kentucky  -0  2  -6  -0  1  ---4  16  38  97  Mississippi  -0  1  2  2  -0  1  2  --1  8  5  17  Tennessee  §  -0  2  3  3  -0  1  -2  1  3  11  37  66 W.S. Central  -1  11  23  34  -2  16  36  13  23  54  263  256  800  Arkansas  §  -0  1  6  3  -0  1  -1  -2  17  15  45  Louisiana  -0  1  5  8  -0  2  -1  -1  3  3  11  Oklahoma  -0  2  3  12  -0  1  1  -6  1  92  17  3  Texas  §  -1  9  9  11  -2  15  35  11  17  44  157  221  741   Mountain  1  1  6  19  19  -0  4  1  4  13  41  99  623  307  Arizona  -0  2  7  6  -0  1  -1  3  12  29  225  118  Colorado  -0  4  1  4  -0  1  -3  10  12  63  236  34  Idaho  §  -0  1  3  1  -0  1  ---2  15  29  43  Montana  §  -0  2  2  1  -0  0  ---2  16  46  5  Nevada  §  -0  1  2  4  -0  1  ---0  7  8  1  New Mexico  §  1  0  1  1  2  -0  2  1  --2  11  29  29  Utah  -0  1  3  1  -0  1  ---6  16  48  76  Wyoming  §  -0  1  ---0  1  ---0  2  2  1   Pacific  1  3  15  58  58  -0  18  6  4  12  150  1,101  637  325  Alaska  -0  1  ---0  1  1  1  -1  6  14  6  California  -2  10  38  43  -0  18  --11  130  959  475  202  Hawaii  -0  1  2  1  -0  1  2  1  -1  6  8  17  Oregon  -1  3  14  10  -0  1  3  1  1  5  12  53  70  Washington  1  0  4  4  4  -0  2  -1  -10  132  87 30 Table IV , which appears quarterly. † Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I . § Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
S. Atlantic
1 - - 0 2 - 1 - 0 1 - - Montana † - 0 1 - 1 - 0 1 - - - 0 1 - - Nevada † - 0 2 3 10 - 0 1 - - - 0 2 3 2 New Mexico † - 0 2 2 2 - 0 2 1 - - 0 1 2 - Utah - 0 2 4 9 - 0 1 - 1 - 0 0 - 3 Wyoming † - 0 2 1 - - 0 0 - - - 0 0 - - PacificTerritories American Samoa - 0 0 - - N 0 0 N N - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 1 - - - 0 0 - - - 0 0 - - Puerto Rico - 0 0 - - N 0 0 N N - 0 1 - 3 U.S. Virgin Islands - 0 0 - - - 0 0 - - - 0 0 - - C.N.Territories American Samoa - 0 0 - - - 0 0 - - - 0 0 - - C.N.M.I. - - - - - - - - - - - - - - - Guam - 0 0 - - - 1 15 12 7 - 0 14 28 - Puerto Rico - 0 0 - - - 0 1 - - - 0 1 1 - U.S. Virgin Islands - 0 0 - - - 0 0 - - - 0 0 - - C.N.
Territories
American -0  3  6  16  -7  21  15  154  -0 Table IV , which appears quarterly. † Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused by Rickettsia rickettsii, is the most common and well-known spotted fever. § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). Table IV , which appears quarterly. † Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from a normally sterile body site (e.g., blood or cerebrospinal fluid). § Contains data reported through the National Electronic Disease Surveillance System (NEDSS). 30  41  202  642  969  -0  16  ---0  3  --Arkansas  ¶  1  3  17  60  81  -0  3  ---0  1  --Louisiana  -1  4  13  24  -0  3  ---0  1  --Oklahoma  N  0  0  N  N  -0  1  ---0  0  --Texas  ¶  29  37  191  569  864  -0  15  ---0  2  --Mountain  5  17  50  291  430  -0  18  ---0  15  --Arizona  -0  0  ---0  13  ---0  9  --Colorado  ¶  4  7  31  111  147  -0  5  ---0  11  --Idaho  ¶  N  0  0  N  N  -0  0  ---0  1  --Montana  ¶  1  3  28  77  78  -0  0  ---0 Table IV , which appears quarterly. † Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I . § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenzaassociated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/osels/ph_surveillance/nndss/phs/infdis.htm. ¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
